EDIUNET Free equity investment tool of Japanese companies

Companies Cart
@
Credit Rating Analysis
Annual
First quarter
Second quarter
Third quarter
Sponsored Link
Related Company
@ KUMIAI CHEMICAL INDUSTRY
@ Nissan Chemical Industries
@ SAWAI PHARMACEUTICAL
@ キョーリン製薬ホールディングス
@ Takeda Pharmaceutical
@ 東京応化工業
@ ONO PHARMACEUTICAL
@ 積水樹脂
@ NIPPON KAYAKU
@ Sekisui Chemical
@ Nichi-Iko Pharmaceutical
@ Dainippon Sumitomo Pharma
@ 千寿製薬
@ Kao
@ ADEKA
EDIUNET Related Ranking
EDIUNET
EDIUNET Credit Rating
EDIUNET Industry Avg
EDIUNET Prefectures
Yuho! Industry
EDIUNET Rating News
Prev « 2024-04 » Next
Mon Tue Wed Thu Fri Sat Sun
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
[Update list]
1/28 Retail Trade (CAWACHI:A etc...
1/27 Banks (The Awa Bank:BBB→A)
1/23 Chemicals (Milbon:AA→AAA)
1/21 Glass & Ceramics Products (..
1/21 Machinery (TSUDAKOMA:C)
1/21 Other Services (Netindex.:CC)
1/20 Other Products (Kurogane Kos..
1/20 Wholesale Trade (リーバイ・..
1/20 Other Services (川崎地質:BB→..
1/17 Chemicals (Kawaguchi Chemica..
 RSS
 Company RSS
 Daily RSS
Sponsored Link
Recently Download Chart
PIONEER
graph
Renesas Electronics
graph
PIONEER etc.
graph
日本セラミック etc.
graph
日本セラミック etc.
graph

Credit Rating Analysis: キッセイ薬品工業 (Annual )

The details of credit rating (bankruptcy risk) can be checked. A credit rating in nine stages (AAA-C).

【Analysis Menu】 @Outline @Statement @Rating @Indicator @Download

Sponsored Link

Credit Rating (Bankruptcy Risk): キッセイ薬品工業 (Annual ) Consolidated | Non-Consolidated

Date Credit Rating Comment Sales Current Profit Net Income
2013-03-31  BB  Credit is a little enough, but be insufficient potential by biz environs. ¥ 62 B
-3.29%
¥ 8 B
6.28%
¥ 5 B
5.24%

Financial Timeline

Date  2012-12-31 
(Third quarter )
 2013-03-31 
(Annual )
 2013-06-30 
(First quarter )
 2013-09-30 
(Second quarter )
Credit Rating BBBBAAAAA
Total Assets
¥ 147 B
¥ 160 B
¥ 158 B
¥ 161 B
Net Assets
¥ 127 B
¥ 134 B
¥ 133 B
¥ 136 B

Financial Statement Risk Analysis: キッセイ薬品工業 (Annual ) (Consolidated )

[Date: 2013-03-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 62 B) is first term Sales (¥ 64 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Gross Income is decrease )
Gross Income (¥ 21 B) is first term Gross Income (¥ 22 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -2 B) & Financial Cash Flow (¥ -2 B) is a minus, Operating Cash Flow (¥ 9 B) is a plus,
Dividend
Under the situation of Net Income (¥ 5 B) & Operating Cash Flow (¥ 9 B) , Dividend (¥ -1 B) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 771 M) is Sales first term ratio (¥ -2 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2012-03-31]  Danger : Warning : Caution : Good
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -2 B) & Financial Cash Flow (¥ -6 B) is a minus, Operating Cash Flow (¥ 5 B) is a plus,
Dividend
Under the situation of Net Income (¥ 4 B) & Operating Cash Flow (¥ 5 B) , Dividend (¥ -1 B) is paid.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 818 M) is Sales first term ratio (¥ 225 M) more , there is a possibility that the non-performing asset was increased.
[Date: 2011-03-31]  Danger : Warning : Caution : Good
Management Risk (*Net Income is decrease )
Net Income (¥ 4 B) is first term Net Income (¥ 4 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Net Profit Margin is decrease )
Net Profit Margin (6.22%) is first term Net Profit Margin (7.03%) less , there is a possibility that the profitability has deteriorated.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -1 B) is a minus, Operating Cash Flow (¥ 4 B) is a plus,
Dividend
Under the situation of Net Income (¥ 4 B) & Operating Cash Flow (¥ 4 B) , Dividend (¥ -1 B) is paid.
Financing Risk (*Operating Cash Flow is decrease )
Sales (¥ 64 B) is first term (¥ 62 B) more, however Operating Cash Flow (¥ 4 B) is first term (¥ 10 B) less , there is a possibility that the financing has deteriorated very much.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ 3 B) is Sales first term ratio (¥ 2 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2010-03-31]  Danger : Warning : Caution : Good
Management Risk (*Sales is decrease )
Sales (¥ 62 B) is first term Sales (¥ 64 B) less , there is a possibility that the management situation has stagnated and deteriorated
Management Risk (*Gross Income is decrease )
Gross Income (¥ 21 B) is first term Gross Income (¥ 23 B) less , there is a possibility that the management situation has stagnated and deteriorated
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -3 B) & Financial Cash Flow (¥ -1 B) is a minus, Operating Cash Flow (¥ 10 B) is a plus,
Dividend
Under the situation of Net Income (¥ 4 B) & Operating Cash Flow (¥ 10 B) , Dividend (¥ -1 B) is paid.
Financing Risk (*Interest-bearing Debt more)
Sales first term ratio (¥ -2 B) & Operating Cash Flow first term ratio (¥ -884 M) is a minus, Interest-bearing Debt (¥ 3 B) is first term Interest-bearing Debt (¥ 3 B) more , there is a possibility that the financing has deteriorated very much.
Non-performing asset Risk (*Accounts Receivable and Inventory, etc. confirmed content)
Other Current Assets first term ratio (¥ -2 B) is Sales first term ratio (¥ -2 B) more , there is a possibility that the non-performing asset was increased.
[Date: 2009-03-31]  Danger : Warning : Caution : Good
Financing Risk (*Issuance of new shares)
Financial Cash Flow (¥ -13 B) is a minus, Issuance of new shares (¥ 170 M) is plus. Because a possibility of having appropriated the capital-increase fund for repayment of borrowed money is high , there is a possibility that the financing is extremely severe.
Financing Good (*Operating Cash Flow is plus )
Investment Cash Flow (¥ -1 B) & Financial Cash Flow (¥ -13 B) is a minus, Operating Cash Flow (¥ 11 B) is a plus,
Dividend
Under the situation of Net Income (¥ 2 B) & Operating Cash Flow (¥ 11 B) , Dividend (¥ -1 B) is paid.

Related Information: キッセイ薬品工業 (Annual )

Statement Type
Annual : キッセイ薬品工業
First quarter : キッセイ薬品工業
Second quarter : キッセイ薬品工業
Third quarter : キッセイ薬品工業
Analysis Menu
@Outline : キッセイ薬品工業
@Statement : キッセイ薬品工業
@Rating : キッセイ薬品工業
@Indicator : キッセイ薬品工業
@Download : キッセイ薬品工業
Industry Comparison Ranking
Chemicals - EDIUNET Industry Rankings
Chemicals - EDIUNET Credit Rating
Chemicals - EDIUNET Industry Avg
Comparison with a neighboring company
Nagano - EDIUNET Prefectures
Nagano松本市 - EDIUNET Prefectures

Related company's newest statement

Date Company Credit Rating Date
1/23 Milbon AA→AAA 2013-12-20
1/17 Kawaguchi Chemical Indu.. BBB→BB 2013-11-30
1/17 SANKEI CHEMICAL A 2013-11-30
1/15 HOKKO CHEMICAL INDUSTRY BB→B 2013-11-30
1/15 Daito Pharmaceutical Co . AA 2013-11-30 (Q2)
1/15 KAWAKAMI PAINT MFG. B→BB 2013-11-30
1/15 旭化学工業 AA 2013-11-30 (Q1)
1/10 OSAKA ORGANIC CHEMICAL .. BB→BBB 2013-11-30
1/10 HISAMITSU PHARMACEUTICAL A 2013-11-30 (Q3)
1/10 AMS Life Science BBB→BB 2013-11-30 (Q1)

Ticker Market Industry Month report Rating
@ キッセイ薬品工業 4547 TSE 1st Chemicals 3 Annual BB

Related Company

@ キョーリン製薬ホールディングス (Sales ¥ 107 B)
@ Kao (Sales ¥ 1.0 T)
@ SAWAI PHARMACEUTICAL (Sales ¥ 80 B)
@ Aica Kogyo (Sales ¥ 101 B)
@ TOWA PHARMACEUTICAL (Sales ¥ 55 B)
@ エスケー化研 (Sales ¥ 82 B)
@ 積水樹脂 (Sales ¥ 64 B)
@ Nichi-Iko Pharmaceutical (Sales ¥ 93 B)
@ Sekisui Chemical (Sales ¥ 1.0 T)
@ NIPPON KAYAKU (Sales ¥ 128 B)
@ 千寿製薬 (Sales ¥ 28 B)
@ 持田製薬 (Sales ¥ 89 B)
@ Nissan Chemical Industries (Sales ¥ 153 B)
Sponsored Link


関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .

▲ Go to the top ▲

  1. Guide
  2. Mobile
  3. Tablet
  4. Japanese
`EDIUNET` Copyright©2006-2024 `MAバンク` (0.090 sec.)